Cargando…
Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
BACKGROUND: Nanostructured lipid carriers (NLCs), composed of solid and liquid lipids, and surfactants are potentially good colloidal drug carriers. Thymoquinone is the main bioactive compound of Nigella sativa. In this study, the preparation, gastroprotective effects, and pharmacokinetic (PK) prope...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692342/ https://www.ncbi.nlm.nih.gov/pubmed/23818776 http://dx.doi.org/10.2147/IJN.S44108 |
_version_ | 1782274601055682560 |
---|---|
author | Abdelwahab, Siddig Ibrahim Sheikh, Bassem Yousef Taha, Manal Mohamed Elhassan How, Chee Wun Abdullah, Rasedee Yagoub, Umar El-Sunousi, Rashad Eid, Eltayeb EM |
author_facet | Abdelwahab, Siddig Ibrahim Sheikh, Bassem Yousef Taha, Manal Mohamed Elhassan How, Chee Wun Abdullah, Rasedee Yagoub, Umar El-Sunousi, Rashad Eid, Eltayeb EM |
author_sort | Abdelwahab, Siddig Ibrahim |
collection | PubMed |
description | BACKGROUND: Nanostructured lipid carriers (NLCs), composed of solid and liquid lipids, and surfactants are potentially good colloidal drug carriers. Thymoquinone is the main bioactive compound of Nigella sativa. In this study, the preparation, gastroprotective effects, and pharmacokinetic (PK) properties of thymoquinone (TQ)-loaded NLCs (TQNLCs) were evaluated. METHOD: TQNLCs were prepared using hydrogenated palm oil (Softisan® 154), olive oil, and phosphatidylcholine for the lipid phase and sorbitol, polysorbate 80, thimerosal, and double distilled water for the liquid lipid material. A morphological assessment of TQNLCs was performed using various methods. Analysis of the ulcer index, hydrogen concentration, mucus content, and biochemical and histochemical studies confirmed that the loading of TQ into the NLCs significantly improved the gastroprotective activity of this natural compound against the formation of ethanol-induced ulcers. The safety of TQNLC was tested on WRL68 liver normal cells with cisplatin as a positive control. RESULTS: The average diameter of the TQNLCs was 75 ± 2.4 nm. The particles had negative zeta potential values of −31 ± 0.1 mV and a single melting peak of 55.85°C. Immunohistochemical methods revealed that TQNLCs inhibited the formation of ethanol-induced ulcers through the modulation of heat shock protein-70 (Hsp70). Acute hepatotoxic effects of the TQNLCs were not observed in rats or normal human liver cells (WRL-68). After validation, PK studies in rabbits showed that the PK properties of TQ were improved and indicated that the drug behaves linearly. The T(max), C(max), and elimination half-life of TQ were found to be 3.96 ± 0.19 hours, 4811.33 ± 55.52 ng/mL, and 4.4933 ± 0.015 hours, respectively, indicating that TQ is suitable for extravascular administration. CONCLUSION: NLCs could be a promising vehicle for the oral delivery of TQ and improve its gastroprotective properties. |
format | Online Article Text |
id | pubmed-3692342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36923422013-07-01 Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration Abdelwahab, Siddig Ibrahim Sheikh, Bassem Yousef Taha, Manal Mohamed Elhassan How, Chee Wun Abdullah, Rasedee Yagoub, Umar El-Sunousi, Rashad Eid, Eltayeb EM Int J Nanomedicine Original Research BACKGROUND: Nanostructured lipid carriers (NLCs), composed of solid and liquid lipids, and surfactants are potentially good colloidal drug carriers. Thymoquinone is the main bioactive compound of Nigella sativa. In this study, the preparation, gastroprotective effects, and pharmacokinetic (PK) properties of thymoquinone (TQ)-loaded NLCs (TQNLCs) were evaluated. METHOD: TQNLCs were prepared using hydrogenated palm oil (Softisan® 154), olive oil, and phosphatidylcholine for the lipid phase and sorbitol, polysorbate 80, thimerosal, and double distilled water for the liquid lipid material. A morphological assessment of TQNLCs was performed using various methods. Analysis of the ulcer index, hydrogen concentration, mucus content, and biochemical and histochemical studies confirmed that the loading of TQ into the NLCs significantly improved the gastroprotective activity of this natural compound against the formation of ethanol-induced ulcers. The safety of TQNLC was tested on WRL68 liver normal cells with cisplatin as a positive control. RESULTS: The average diameter of the TQNLCs was 75 ± 2.4 nm. The particles had negative zeta potential values of −31 ± 0.1 mV and a single melting peak of 55.85°C. Immunohistochemical methods revealed that TQNLCs inhibited the formation of ethanol-induced ulcers through the modulation of heat shock protein-70 (Hsp70). Acute hepatotoxic effects of the TQNLCs were not observed in rats or normal human liver cells (WRL-68). After validation, PK studies in rabbits showed that the PK properties of TQ were improved and indicated that the drug behaves linearly. The T(max), C(max), and elimination half-life of TQ were found to be 3.96 ± 0.19 hours, 4811.33 ± 55.52 ng/mL, and 4.4933 ± 0.015 hours, respectively, indicating that TQ is suitable for extravascular administration. CONCLUSION: NLCs could be a promising vehicle for the oral delivery of TQ and improve its gastroprotective properties. Dove Medical Press 2013 2013-06-17 /pmc/articles/PMC3692342/ /pubmed/23818776 http://dx.doi.org/10.2147/IJN.S44108 Text en © Abdelwahab et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Abdelwahab, Siddig Ibrahim Sheikh, Bassem Yousef Taha, Manal Mohamed Elhassan How, Chee Wun Abdullah, Rasedee Yagoub, Umar El-Sunousi, Rashad Eid, Eltayeb EM Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
title | Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
title_full | Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
title_fullStr | Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
title_full_unstemmed | Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
title_short | Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
title_sort | thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692342/ https://www.ncbi.nlm.nih.gov/pubmed/23818776 http://dx.doi.org/10.2147/IJN.S44108 |
work_keys_str_mv | AT abdelwahabsiddigibrahim thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT sheikhbassemyousef thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT tahamanalmohamedelhassan thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT howcheewun thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT abdullahrasedee thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT yagoubumar thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT elsunousirashad thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration AT eideltayebem thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration |